EX-99 2 jfi.txt ADDITIONAL EXHIBITS EXHIBIT 99 FORM 4 JOINT FILER INFORMATION ADDITIONAL REPORTING PERSON: Novartis Pharma AG ADDRESS: Lichstrasse 35 CH-4002, Basel Switzerland DESIGNATED FILER: Novartis AG ISSUER AND TICKER SYMBOL: Idenix Pharmaceuticals, Inc. (IDIX) DATE OF EVENT REQUIRING STATEMENT: October 31, 2005 Novartis Pharma AG By: /s/ Matthias Runge November 2, 2005 ----------------------------------- ---------------- Name: Matthias Runge Date Title: Head of Legal Ophtha and Oncology Europe By: /s/ Joseph E. Mamie November 2, 2005 ----------------------------------- ---------------- Name: Joseph E. Mamie Date Title: Head Operational Treasury
Page 3 of 3